Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 29, 2015 7:32 AM ET

Pharmaceuticals

Company Overview of Nuron Biotech Inc.

Executive Profile

Paul Leber M.D.

Former Regulatory Advisor, Marinus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Mr. Paul Leber, M.D. served as Regulatory Advisor of Marinus Pharmaceuticals, Inc. Dr. Leber serves as Member of Development Advisory Board at Prestwick Pharmaceuticals Inc. He serves as Member of Scientific Advisory Board at Nuron Biotech Inc. Dr. Leber serves as Director of NeuroPharm LLC and served as Director of the Neuropharmacological Drug Products Division, Office of New Drugs, FDA.

Corporate Headquarters

1 East Uwchlan Avenue
Exton, Pennsylvania 19341

United States

Phone: 610-968-6700
Fax: 610-968-6650

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez MBAChief Executive Officer
Novartis AG
$6.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nuron Biotech Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.